08th week of 2009 patent applcation highlights part 31 |
Patent application number | Title | Published |
20090047308 | GRADIENT COPOLYMER, COMPOSITION INCLUDING SAME AND COSMETIC MAKE-UP OR CARE METHOD - Novel gradient copolymers including at least two different and specifically selected monomers, and cosmetic or skin-care compositions including same. The invention also relates to a cosmetic method for make-up or the care of keratin materials, in particular the skin of the body or of the face, the nails, the hair and/or the eyelashes, comprising the application of a cosmetic composition as defined above on said materials. | 2009-02-19 |
20090047309 | COSMETIC METHODS AND COMPOSITIONS FOR REPAIRING HUMAN SKIN - The present invention relates to methods and compositions for repairing adverse effects of the environment, daily stress, sun exposure, or pre-mature aging on human skin, comprising applying to the skin, prior to a period of bodily rest, a topical composition that contains resveratrol or a derivative thereof and at least one DNA repair enzyme. | 2009-02-19 |
20090047310 | Use of a griffonia extract, in particular griffonia simplicifolia, in a cosmetic or dermatological composition for mitigating pigmentation of skin and skin appendages - Use of an extract of | 2009-02-19 |
20090047311 | Antibacterial Agent Composed of Silver-Containing Aluminum Sulfate Hydroxide Particles and Use Thereof - An antibacterial agent composed of silver-containing aluminum sulfate hydroxide particles represented by the following formula (X-I) or (Y-I). | 2009-02-19 |
20090047312 | Microgel and external compositions containing the same - The present invention provides a microgel having a mean particle size of 0.1-1,000 μm, the microgel being produced from a gel which is formed by use of a hydrophilic compound capable of forming a gel. An external composition containing the microgel provides an excellent sensation during use; i.e., the composition provides neither sticky sensation during use nor frictional sensation. Furthermore, even when a large amount of a pharmaceutical ingredient, such as a whitening ingredient, or a salt is incorporated into the composition, the viscosity of the composition is not lowered, and the composition exhibits excellent viscosity increasing property. In addition, the composition exhibits long-term stability, without inviting separation of water. | 2009-02-19 |
20090047313 | PREPARATION HAVING SKIN-MOISTURIZING PROPERTIES - A permanently skin-moisturizing cosmetic preparation and use thereof. | 2009-02-19 |
20090047314 | MICROENCAPSULATION SYSTEMS AND APPLICATIONS OF SAME - The invention relates to microencapsulation systems which are characterised in that they are developed from oily substances or sugars and in that they form an essentially organised assembly corresponding to stacks of crystalline structures. The inventive systems can be used for the microencapsulation of one or more substances which are of interest, such as therapeutically-active substances, or which can be used in cosmetics. | 2009-02-19 |
20090047315 | POROUS MAGNESIA AND PROCESS FOR PREPARING THE SAME - The present invention relates to porous magnesia of substantially spherical shape having a silica layer, which may be used as a carrier for deodorants, antibacterials, catalysts, slow action agents (the adsorbent having the possibility of decreasing the effect of the co-administered medicines or fertilizer and plastic additives, and body pigments. | 2009-02-19 |
20090047316 | Porous particles loaded with cosmetically or pharmaceutically active compounds - Individualized porous particles have a volume-average diameter of less than or equal to 10 μm and a specific surface area of greater than or equal to 1 m | 2009-02-19 |
20090047317 | Disinfectant Delivery System and Method of Providing Alcohol-Free Disinfection - A disinfectant delivery system and method of providing alcohol-free disinfection to a body to be disinfected, as well as a method of infection reduction by preparation of a patient before an invasive procedure. A blended cloth comprising first fibers and second fibers is provided with the first fibers generally being greater in quantity by weight than the second fibers. A disinfectant solution impregnates the blended cloth, with the disinfectant solution having chlorhexidine gluconate as an active ingredient and having no alcohol. In the method according to the invention, at least one impregnated blended cloth is used to disinfect at least a portion of a body. A plurality of blended cloths can be provided for disinfecting discrete portions of the body. When an invasive procedure is to be performed on a patient, a further method according to the invention of infection reduction comprises using a CHG-impregnated cloth to disinfect at least a portion of the patient at least one day prior to the invasive procedure proximate the location of the invasive procedure. | 2009-02-19 |
20090047318 | NANOPARTICLE-COATED MEDICAL DEVICES AND FORMULATIONS FOR TREATING VASCULAR DISEASE - Nanoparticle-coated medical devices, nanoparticle-containing formulations and methods of using for treating a vascular disease are disclosed. | 2009-02-19 |
20090047319 | Pharmaceutical composition for obstructive vascular disease - Provided is the excellent prevention or treatment of a vascular occlusive disease such as vascular restenosis. A pharmaceutical composition for a obstructive vascular disease comprising a nucleic acid construct capable of inhibiting the expression of a midkine gene through RNA interference and a collagen molecule. The use of the nucleic acid construct capable of inhibiting the expression of an MK protein through RNA interference in the presence of the collagen molecule can provide an excellent inhibitory effect on the thickened vascular intima. | 2009-02-19 |
20090047320 | Apparatus and Method for Reducing the Occurrence of Post-Surgical Adhesions - A method for inhibiting formation of adhesions following abdominal surgery which involves application of an anti-static fatty acid ethoxylated amide (Cocamide DEA) in a matrix that is placed in the peritoneal cavity at the conclusion of an abdominal surgery and which releases this anti-adhesive chemical over a predetermined time in a range from about five to seven days. Tests conducted on laboratory rats established that the method reduced the incidences of adhesions from 100 percent (100%) in a test model to near zero percent (0%) in the treated animals. In an alternative embodiment, Andrographalide was delivered through a drug pump with similar results. In still another embodiment, an effective amount of Rapamune was delivered, via a pump, into the abdominal cavity, again with similar results. | 2009-02-19 |
20090047321 | ANTIMICROBIAL COMPOUNDS HAVING PROTECTIVE OR THERAPEUTIC LEAVING GROUPS - Antimicrobial compounds, such as silanol or alcohol, include a protecting or leaving group that can protect the compound from degradation during the process of preparing a medical device containing the compound or reduce the volatility of the compound relative to its counterpart without the leaving group. Nearly any hydrolysable leaving group may be employed. The leaving group may be an agent that may serve a therapeutic function in addition to protecting or retaining the antimicrobial agents. | 2009-02-19 |
20090047322 | Degradable Hydrophilic Block Copolymers with Improved Biocompatibility for Soft Tissue Regeneration - The present application discloses biodegradable polymers, to porous and other materials comprising such polymers, and to various medical uses of such materials, including use as a scaffold for supporting cell adhesion or the in-growth for regeneration of tissue. The polymer is of the formula A—O—(CHR | 2009-02-19 |
20090047323 | Medical Devices Containing Rapamycin Analogs - A medical device comprising a supporting structure capable of containing or supporting a pharmaceutically acceptable carrier or excipient, which carrier or excipient may contain one or more therapeutic agents or substances, with the carrier preferably including a coating on the surface thereof, and the coating containing the therapeutic substances, such as, for example, drugs. Supporting structures for the medical devices that are suitable for use in this invention include, but are not limited to, coronary stents, peripheral stents, catheters, arterio-venous grafts, by-pass grafts, and drug delivery balloons used in the vasculature. Drugs that are suitable for use in this invention include, but are not limited to Formula (I). This drug can be used in combination with another drug including those selected from anti-proliferative agents, anti-platelet agents, anti-inflammatory agents, anti-thrombotic agents, cytotoxic drugs, agents that inhibit cytokine or chemokine binding, cell de-differentiation inhibitors, anti-lipaedemic agents, matrix metalloproteinase inhibitors, cytostatic drugs, or combinations of these drugs. | 2009-02-19 |
20090047324 | Medical Devices Containing Rapamycin Analogs - A medical device comprising a supporting structure capable of containing or supporting a pharmaceutically acceptable carrier or excipient, which carrier or excipient may contain one or more therapeutic agents or substances, with the carrier preferably including a coating on the surface thereof, and the coating containing the therapeutic substances, such as, for example, drugs. Supporting structures for the medical devices that are suitable for use in this invention include, but are not limited to, coronary stents, peripheral stents, catheters, arterio-venous grafts, by-pass grafts, and drug delivery balloons used in the vasculature. Drugs that are suitable for use in this invention include, but are not limited to Formula (I). This drug can be used in combination with another drug including those selected from anti-proliferative agents, anti-platelet agents, anti-inflammatory agents, anti-thrombotic agents, cytotoxic drugs, agents that inhibit cytokine or chemokine binding, cell de-differentiation inhibitors, anti-lipaedemic agents, matrix metalloproteinase inhibitors, cytostatic drugs, or combinations of these drugs. | 2009-02-19 |
20090047325 | XENOTRANSPLANT FOR CNS THERAPY - Disclosed are compositions and methods for the xenotransplantation treatment of neurological diseases of the central nervous system of a mammal. | 2009-02-19 |
20090047326 | SINUS DELIVERY OF SUSTAINED RELEASE THERAPEUTICS - The invention provides biodegradable implants for treating sinusitis. The biodegradable implants have a size, shape, density, viscosity, and/or mucoadhesiveness that prevents them from being substantially cleared by the mucociliary lining of the sinuses during the intended treatment period. The biodegradable implants include a sustained release therapeutic, e.g., an antibiotic, a steroidal anti-inflammatory agent, or both. The biodegradable implants may take various forms, such as rods, pellets, beads, strips, or microparticles, and may be delivered into a sinus in various pharmaceutically acceptable carriers. | 2009-02-19 |
20090047327 | SINUS DELIVERY OF SUSTAINED RELEASE THERAPEUTICS - The invention provides biodegradable implants for treating sinusitis. The biodegradable implants have a size, shape, density, viscosity, and/or mucoadhesiveness that prevents them from being substantially cleared by the mucociliary lining of the sinuses during the intended treatment period. The biodegradable implants include a sustained release therapeutic, e.g., an antibiotic, a steroidal anti-inflammatory agent, or both. The biodegradable implants may take various forms, such as rods, pellets, beads, strips, or microparticles, and may be delivered into a sinus in various pharmaceutically acceptable carriers. | 2009-02-19 |
20090047328 | CAFFEINE DELIVERY SYSTEMS - Described are caffeine-based delivery vehicles. A first delivery vehicle is a malleable strip that dissolves in an oral cavity. Buccal absorption provides a prompt mental and physical stimulation for the user. The strips are formulated with beneficial ingredients comprising caffeine, taurine and/or nitric oxide. The strips are contained in a small crush-proof package for convenience. A second delivery vehicle is a gel. The gel provides a prompt and sustained effect. The sustained effect based on gastric absorption of ingested gel that does not absorb through contact with a user's oral cavity. A high viscosity of the gel enhances the buccal absorption. Like the strips, the gel is formulated with beneficial ingredients comprising caffeine, taurine and/or nitric oxide. The gel is contained in packages having an integrated, re-sealable straw. | 2009-02-19 |
20090047329 | MESOCELLULAR OXIDE FOAMS AS HEMOSTATIC COMPOSITIONS AND METHODS OF USE - The present invention relates to hemostatic compositions comprising a mesocellular oxide foam and, optionally, a biologically active agent such as a procoagulant, as well as devices and methods of use to promote blood clotting. | 2009-02-19 |
20090047331 | SUSTAINED RELEASE FILM FORMULATION FOR HEALING WOUND COMPRISING EPIDERMAL GROWTH FACTOR - The present invention relates to a sustained release film formulation for healing wound comprising epidermal growth factor, chitosan, viscosity modifiers, plasticizers, and stabilizers. Specifically, the present invention relates to a sustained release film formulation for healing wound comprising epidermal growth factor as an effective ingredient and chitosan as a main base, and additionally comprising one or more antioxidants selected from the group consisting of EDTA and vitamin C; one or more viscosity modifiers selected from the group consisting of hydroxypropylmethylcellulose, gellan gum and pullulan; and one or more plasticizers selected from the group consisting of glycerin, propylene glycol, polyethylene glycol, polyvinyl alcohol and polyvinylpyrrolidone thereto. When the present film is attached to wound site, it absorbs exudation from wound site, and so is changed to hydrogel to keep wound site humid, which is good for wound-healing. And, the present film has superior attachment property to human body, and antifungal activity. Thus, the present film has more merits than simple ointment/cream formulation. | 2009-02-19 |
20090047332 | METHODS FOR PRODUCING SILVER-BONDED ANTIMICROBIAL MOIST WOUND DRESSINGS AND MOIST WOUND DRESSINGS PRODUCED BY THE METHODS - A method for producing a silver-bonded antimicrobial moist wound dressing. A silver-containing compound is added to a 0.1-30% aqueous solution of an alkaline solvent to dissociate silver ions from the silver-containing compound, dissolving CMC in water or an organic solvent to obtain a CMC solution, the silver ion-containing solution is mixed with the CMC solution so that the hydrogen ions (H | 2009-02-19 |
20090047333 | Pressure-sensitive adhesive composition applicable to nail and adhesive agent for nail - The present invention aims at providing a pressure-sensitive adhesive composition applicable to nail, which shows superior adhesive performance (adhesive force, cohesion etc.), and superior drug releasability and drug stability, and an adhesive agent for nail, which uses this composition. The composition of the present invention contains a condensation polymer of a silicone resin and a silicone rubber. The composition of the present invention preferably contains not less than two kinds of condensation polymers having different resin/rubber ratios. The adhesive agent of the present invention has a support and an adhesive layer formed on one surface of the support, which contains the above-mentioned composition. | 2009-02-19 |
20090047334 | TRANSDERMAL PATCH FOR EXTENDED DELIVERY OF CALCIUM - The present invention relates to a method for delivery of calcium that avoids the problems with orally given calcium tablets. Particularly, the present invention is a transdermal patch for providing between 40 mg and 500 mg of bioavailable calcium to a patient. | 2009-02-19 |
20090047335 | Anti-angiogenic peptides and methods of use thereof - Anti-angiogenic peptides that inhibit VEGF-mediated activation or proliferation of endothelial cells are disclosed. Such peptides may be used to inhibit VEGF binding to the VEGFR2 receptor (also known as the kinase domain receptor or KDR). Such peptides may also be used to inhibit VEGF-mediated activation of endothelial cells in angiogenesis-associated diseases such as cancer, inflammatory diseases, eye diseases and skin disorders. | 2009-02-19 |
20090047336 | NOVEL FORMULATION OF DEHYDRATED LIPID VESICLES FOR CONTROLLED RELEASE OF ACTIVE PHARMACEUTICAL INGREDIENT VIA INHALATION - A new formulation of dehydrated lipid vesicles employs a vesicle preserver and permits the control of release and delivery of active pharmaceutical ingredients into the respiratory system for treatment in particular of asthma. The typical formulation provides controlled release of the active pharmaceutical ingredient from 0% to 100% from 0 to 72 hours after inhalation, changes the systemic administration to topical administration, allows prolonged therapeutic period for one administration, increased stability, with reduced dose, reduced systemic side effects, reduced toxicity. | 2009-02-19 |
20090047337 | Method of administering a cationic liposomal preparation - The present invention relates to the use of pharmaceutical preparations comprising paclitaxel for administration to a human patient in need thereof. | 2009-02-19 |
20090047338 | Method to Treat Flavivirus Infection with siRNA - The present invention is directed to methods of treating flavivirus mediated diseases using siRNAs. The invention is based upon our findings in a mouse model that siRNAs directed against sequences conserved among multiple flaviviruses prevents and treats flavivirus infections. Accordingly, the present invention provides an isolated siRNA comprising a sense RNA and an antisense RNA strand or a single strand. The sense and the antisense RNA strands, or the single RNA strand, form an RNA duplex, and wherein the RNA strand comprises a nucleotide sequence identical to a target sequence of about 15 to about 30 contiguous nucleotides in flavivirus mRNA or mutant or variant thereof. | 2009-02-19 |
20090047339 | Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof - The present invention relates to polynucleotides encoding immunogenic HIV type C Gag- and/or Env-containing polypeptides. Uses of the polynucleotides in applications including DNA immunization, generation of packaging cell lines, and production of Gag- and/or Env-containing proteins are also described. | 2009-02-19 |
20090047340 | LIPOSOMAL REDUCED GLUTATHIONE AND 1-ARGININE, INCLUDING WITH OTHER INGREDIENT(S), CAPABLE OF MULTIPATH ADMINISTRATION FOR REVERSAL AND PREVENTION OF OBESITY AND FOR MITOCHONDRIAL BIOGENESIS - The invention enables management of mammalian disease related to decreased energy production in the mitochondria, the powerhouse of the cell. The invention uses the combination of liposomal reduced glutathione and l-arginine to increase the ability weight loss in individuals with excess weight. The mechanism of weight loss appears to be related to improving the inefficient production of energy by the respiratory transport chain of mitochondria, the function of which are influenced positively by the availability of antioxidant nitric oxide in a non-oxidized environment. This invention enables weight loss in individuals who's inability to lose weight is related to inefficiency of the biochemical pathways facilitating mitochondrial function and energy production. The pathways related to inability to lose weight are also related to the phenomenon of the inability to metabolize fats, which results in insulin resistance and diabetes. The invention is useful for the management of the metabolic syndrome. The metabolic syndrome is actually a group of metabolic factors associated with an increased risk of vascular disease problems. The invention is also useful for the resolution of fatigue that accompanies both weight gain and illnesses. The ability of the invention to increase the production of the biochemical agmatine in the central nervous system as well generally in the body is part of the benefit of the combination of liposomal reduced glutathione and l-arginine. In addition, the biochemical pathways stimulated by this invention can have a beneficial effect in individuals suffering from a variety of infectious diseases. | 2009-02-19 |
20090047341 | CAPSULES OF CORE/SHELL TYPE AND PREPARATION PROCESS - The present invention relates to a process for the preparation of a suspension of capsules of core/shell type comprising the steps of mixing, at ambient temperature, an oily phase and polymers, at least one of which is an oligomer having a weight-average molecular weight of less than 10 000 and a hydroxyl number (N | 2009-02-19 |
20090047342 | Methods of Treating Infectious Diseases - The present invention provides methods of treating a human or other mammal infected with a parasitic microorganism by administering an effective amount in unit dosage form of a C | 2009-02-19 |
20090047343 | Method for stabilizing phenylephrine - The present invention relates to a process for stabilizing phenylephrine including drying an acidic solution of phenylephrine and pharmaceutical compositions including stabilized phenylephrine. | 2009-02-19 |
20090047344 | Formulations - The present invention relates to pharmaceutical compositions for oral administration of active compounds. | 2009-02-19 |
20090047345 | Sustained-release tramadol formulations with 24-hour efficacy - A sustained-release tramadol formulation oral administration is provided which, upon initial administration of one dose, provides an analgesic effect within 2 hours, which analgesic effect continues for at least 24 hours after administration | 2009-02-19 |
20090047346 | Sustained release formulations of sotalol - Sustained release compositions of sotalol, or a pharmaceutically acceptable salt thereof, are provided. In certain examples, sotalol, or a pharmaceutically acceptable salt thereof, may be administered in an effective amount to provide a therapeutic effect to a patient, such as, for example, a patient suffering from a cardiac disorder. In some examples, sotalol combined with a sustained release system may be administered to provide a sustained release of sotalol for a desired period, e.g., at least about 24 hours. | 2009-02-19 |
20090047347 | Compositions for Drug Administration - The present invention provides compositions and methods and for speeding the onset of drug action and reducing the first-pass effect drug metabolism in fast-dispersing drug formulations. | 2009-02-19 |
20090047348 | POLY(ORGANOPHOSPHAZENE) HYDROGELS FOR DRUG DELIVERY, PREPARATION METHOD THEREOF AND USE THEREOF - A biodegradable and thermosensitive poly(organophosphazene) with a functional group, a preparation method thereof, and a use thereof for delivery of bioactive substances are provided. | 2009-02-19 |
20090047349 | DRUG DELIVERY DEVICE - Drug delivery devices are provided herein including crosslinked polymeric compositions. The devices may, in embodiments, possess at least two drug release profiles, in embodiments at least three drug release profiles. | 2009-02-19 |
20090047350 | Perforated water soluble polymer based edible films - A novel edible polymer based film dosage form manufactured using natural, synthetic, semisynthetic, pharmaceutically acceptable polymers addressing the issues of swallowing difficulties (Dysphagia and Dynaphagia), of tablet or capsule dosage forms and handling and storage difficulties associated with liquid dosage forms, that also includes materials such as emulsifying agents, suspending agents, buffering agents, effervescence agents, colorants, flavorants, sweetners and specified amounts of bioactive agents preferably having perforations in the body of the dosage form enabling it to disperse/dissolve rapidly upon application by the subject. A flexible film dosage form to accommodate higher drug loads without compromising the fast dispersing/dissolving characteristics is presented. The perforated film system is enabled to be used in various applications such as oral, mucosal and external environments. The perforated film dosage form therefore, additionally allows the usage of polymers that would otherwise have not been used due to insolubility or limited solubility in water. | 2009-02-19 |
20090047351 | Processes For Making Lactose Utilizing Pre-Classification Techniques And Pharmaceutical Formulations Formed Therefrom - A process for forming lactose suitable for use in a pharmaceutical formulation comprises providing a plurality of lactose particles containing no more than 10% w/w of lactose particles having a volume average particle size of about 70 microns or less; milling the plurality of lactose particles to yield a plurality of milled lactose particles with an average particle size, (D50), ranging from about 50 microns to about 100 microns; and classifying the plurality of milled lactose particles into at least two fractions comprising a fine fraction and a coarse fraction wherein the fine fraction has an average particle size, (D50), ranging from about 3 microns to about 50 microns, and the coarse fraction has an average particle size, (D50), ranging from about 40 microns to about 250 microns. | 2009-02-19 |
20090047352 | Colourant Compositions and Their Use - A fibre colourant and an ink composition are provided which comprise monodisperse particles capable of forming a colloidal crystal that diffracts light having a wavelength in a range that corresponds to the wavelength of visible light. The use of such compositions in colouring substrates is also provided. | 2009-02-19 |
20090047353 | CHANGING TH1/TH2 BALANCE IN SPLIT INFLUENZA VACCINES WITH ADJUVANTS - The invention seeks to avoid components in split vaccines that could cause an excessive Th2 response. Thus the invention provides an immunogenic composition comprising a split influenza virus antigen and a Th1 adjuvant, wherein the antigen is preferably prepared from a virus grown in cell culture (e.g., it is free from egg proteins). | 2009-02-19 |
20090047354 | PROCESS FOR THE PREPARATION OF 5-(2-(4-(1,2-BENZISOTHIAZOL-3-YL)-1-PIPERAZINYL) ETHYL)-6-CHLORO-1, 3-DIHYDRO-2H-INDOL-2-ONE HYDROCHLORIDE (ZIPRASIDONE HYDROCHLORIDE) AND ITS INTERMEDIATE - The present invention relates to improved processes for the preparation of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one and its hydrochloride, which is known as Ziprasidone hydrochloride of Formula (I) and 5-(2-Chloro acetyl)-6-chloro oxindole of Formula (IV), which is an intermediate for the preparation of 5-(2-chloro ethyl)-6-chloro oxindole of Formula (V). Ziprasidone hydrochloride of Formula (I) of the present invention is depicted by the following structure. | 2009-02-19 |
20090047355 | PROCESS FOR PRODUCING PULVERULENT PHYTOSTEROL FORMULATIONS - A process for the production of pulverulent phytosterol formulations, includes preparing an aqueous solution, suspension or dispersion of the phytosterol in an aqueous molecular dispersion or colloidal dispersion of a protective colloid and drying. | 2009-02-19 |
20090047356 | TISSUE FACTOR COMPOSITIONS AND METHODS - Tissue Factor (natural or recombinant truncated) can be incorporated into stable, soluble nanoscale particles so that activity is maintained. These particles can be used as a reagent in prothrombin clotting time assays or they can be used in therapeutic compositions for use in humans or animals. Therapeutic settings can include supplementation in the case of a genetic deficiency, uncontrolled bleeding, surgical incisions or seepage, thrombocytopenia, soft tissue trauma or other trauma, to effect tumor regression or to inhibit tumor growth. | 2009-02-19 |
20090047357 | METHOD OF PRODUCING DRUG-CONTAINING WAX MATRIX PARTICLES, EXTRUDER TO BE USED IN THE METHOD AND SUSTAINED-RELEASE PREPARATION CONTAINING CILOSTAZOL - The present invention aims to provide a method for producing, by a simple method, drug-containing wax matrix granules, particularly drug-containing wax matrix granules having an average particle diameter of 1 mm or lower, while avoiding liquid blockage due to the recrystallization of a molten drug during the period from a melting step to a spray step. | 2009-02-19 |
20090047358 | PHOSPHOLIPID-BASED POWDERS FOR DRUG DELIVERY - Phospholipid based powders for drug delivery applications are disclosed. The powders comprise a polyvalent cation in an amount effective to increase the gel-to-liquid crystal transition temperature of the particle compared to particles without the polyvalent cation. The powders are hollow and porous and are preferably administered via inhalation. | 2009-02-19 |
20090047359 | Ointment for combating and treating skin diseases, and process for preparing said ointment - The invention relates to an ointment for treating and curing skin diseases of human beings such as psoriasis, dermatitis, acne, herpes and fungi, consisting of a composition obtained based on ingredients such as white petrolatum, clobetasol propionate, distilled water, rosemary honey, virgin olive oil, white precipitate mercury chloride, salicylic acid, and gentian violet. | 2009-02-19 |
20090047360 | Bone morphogenic protein binding peptide - A cyclized peptide designated BMP Binding Peptide (BBP) is a synthetic peptide that avidly binds rhBMP-2, as do endogenous forms of BBP, and sequence conservation between species results in a variety of useful BBP compositions. BBP increases the over-all osteogenic activity of rhBMP-2, increases the rate at which rhBMP-2 induces bone formation, and BBP induces calcification alone. Compositions and substrates including BBP, and methods of using BBP are useful in therapeutic, diagnostic and clinical applications requiring calcification and osteogenesis. | 2009-02-19 |
20090047361 | Combination of Limited Nutrients and Enhanced Dietary Antioxidants To Impart Improved Kidney Health - This invention is directed to compositions for animal consumption (including foods, treats, etc.), particularly compositions that tend to improve kidney function, and particularly compositions that comprise enhanced antioxidants and reduced quantities of protein and/or phosphorus. This invention also is directed generally to methods for using such compositions. | 2009-02-19 |
20090047362 | Method for in-vitro stabilization of heavy metals - This invention provides a method for reducing the level of 1.0 Normal HCL soluble heavy metals within the human stomach acid environment by oral ingestion of stabilizing agents such that the heavy metal solubility is reduced and subsequent heavy metal transfer to the blood stream is reduced to acceptable levels or eliminated. | 2009-02-19 |
20090047363 | Deodorant Antibacterial Fibrous Product - A deodorant antimicrobial fibrous product containing a cancrinite-like mineral containing an antimicrobial metal, a clay mineral, softwood bleached kraft pulp, and hardwood bleached kraft pulp. The weight ratio of the softwood bleached kraft pulp to hardwood bleached kraft pulp is preferably 95/5 to 50/50. The clay mineral is preferably zeolite, sepiolite or bentonite. The deodorant antimicrobial fibrous product is preferably in the form of a sheet or a broken piece thereof, a granule or a three-dimensional molding. | 2009-02-19 |
20090047364 | Disinfecting methods and compositions - A method of disinfecting surfaces said method comprising applying a disinfectant solution to surface to be disinfected and allowing the solvent to evaporate or wiping the excess solution from the surface after a period of time wherein the solution is an antimicrobial metal ion-acid solution. | 2009-02-19 |
20090047365 | Novel Concomitant Use of Sulfonamide Compound with Anti-Cancer Agent - The present invention relates to a pharmaceutical composition, a kit, a method of treating cancer and/or a method of inhibiting angiogenesis comprising a sulfonamide compound in combination with a platinum complex, a DNA-topoisomerase I inhibitor, an antimetabolite, a microtubule inhibitor or an antibiotic. | 2009-02-19 |
20090047366 | Inorganic Coagulation Accelerators for Individuals taking Platelet Blockers or Anticoagulants - The present invention is a method to accelerate the coagulation of blood through the application of inorganic materials to the wound of a patient on anticoagulant or platelet blocker therapy. The method comprises contacting such wounds with a substance selected from the group consisting of zeolitic molecular sieves and non-zeolitic molecular sieves, diatomaceous earth, glass powder or fibers, precipitated or fumed silica, kaolin and montmorillonite clays and Ca exchanged permutites. | 2009-02-19 |
20090047367 | Pharmaceutical composition for improving anxious behaviors of animals and method for preparing the same - A pharmaceutical composition is disclosed in the present invention, which contains a medical material of | 2009-02-19 |
20090047368 | Polymeric polyphenol extracted from fermented tea, therapeutic agent for mitochondrial disease, preventive/therapeutic agent for diabetes mellitus, and food or beverage - [Problem] To provide a new pharmacological action for high-molecular-weight polyphenols | 2009-02-19 |
20090047369 | Composition Comprising 4-Carbon Dicarboxlic Acids for Improvement of Memory Function - Disclosed herein is a composition for the improvement of memory and learning functions, which contains 4-carbon dicarboxylic acid or a salt thereof and an emulsifying agent. The composition shows a more remarkable effect when it additionally contains a concentrate or alcohol extract of maesil. Because the composition improves learning and memory functions, it is effective for the prevention and treatment of amnesia or dementia and can also be applied as a health supplement food or functional food for this prevention and treatment. | 2009-02-19 |
20090047370 | TOPICAL TREATMENT OF PERIPHERAL NEUROPATHY - A method and composition for the treatment of diabetic neuropathy is disclosed. A preferred embodiment of the invention relates to a topical composition for the treatment of systems related to diabetic neuropathy by application to the affected area. The composition provides relief of these symptoms and inhibits those factors that contribute to these systems, such as an aldose reductase inhibitor A preferred embodiment of the invention relates to a method of treatment for diabetic neuropathy utilizing a regime of administrations of a topical composition in amounts effective to counter those areas of the body affected by peripheral neuropathy. Yet another preferred embodiment of the invention relates to a method of improvement of those areas effected by diabetic peripheral neuropathy using a topical composition over an effective period of time. | 2009-02-19 |
20090047371 | PHARMACEUTICAL COMPOSITION COMPRISING CURCUMIN AND RESVERATROL AND USES THEREOF IN MEDICAL FIELD - The present invention concerns a pharmaceutical composition containing curcumin and resveratrol and its application in the medical field. In particular, the composition according to the invention can be advantageously employed for preventing ageing and vascular diseases, for the treatment and the prophylaxis of cancers as prostate carcinoma, of skin diseases as psoriasis, and of the piliferous system as hair loss. | 2009-02-19 |
20090047372 | PRODUCING A TOPICAL SOLUTION COPOSITION - The invention relates to revitalizing layers of the skin which have been damaged by sunlight exposure and particularly ultraviolet radiation by applying a topical solution composition that includes a concentrated amount of resveratrol which has been extracted from a red wine. | 2009-02-19 |
20090047373 | Bridge Runner System - Disclosed herein is a stationary platen of a mold clamp for use with a molding system. The stationary platen includes a platen base configured to accept a first mold assembly of a mold, the platen base also defines a receptacle for embedding, in use, a bridge runner system. The bridge runner system is configured to fluidly connect, at least in part, a source of molding material with a molding cavity defined, at least in part, by a mold insert accepted in the first mold assembly. | 2009-02-19 |
20090047374 | Mold Module - Disclosed herein is a mold module from a set of substantially structurally independent mold modules of at least one of a first mold assembly or a second mold assembly. The first mold assembly and the second mold assembly for accepting, in use, a plurality of first mold inserts and second mold inserts, respectively, to define, in use, a plurality of substantially identical molding cavities therebetween. A subset of at least one of the first mold inserts or the second mold inserts being accepted in the mold module. | 2009-02-19 |
20090047375 | MOLD TOOL FOR THE PRODUCTION OF EXTRUSION BLOW MOLDED PRODUCTS - The invention concerns a mold tool for the production of extrusion blow molded products, comprising at least three mold portions ( | 2009-02-19 |
20090047376 | Melt Distribution Apparatus - Disclosed herein is a melt distribution apparatus for a molding system having a geometrically balanced network of runners for distributing a melt of molding material from a melt inlet to a rectangular array of melt outlets having a first number of melt outlets in a first reference direction and a second number of melt outlets in a second reference direction, at least one of the first and the second number being an odd number in excess of three. | 2009-02-19 |
20090047377 | Fish Attractant - Disclosed herein is a fish attractant formulation for application to an object. The formulation comprises a carrier which comprises one or more fatty acids; and a further component that is a fish attractant carried by the carrier. The formulation is adapted to be retained on the object. Also disclosed are a fishing lure or bait coated with the fish attractant formulation, and a method for producing a fish attractant formulation. | 2009-02-19 |
20090047378 | NON MARINE OR NON ALGAL SOURCED OMEGA 3 FEED/FOOD SUPPLEMENT AND PROCESS FOR STABILIZING, ENHANCING THE CONVERSION EFFICIENCY, AND ENRICHMENT OF OMEGA 3 FATTY ACIDS IN LIVESTOCK/HUMANS AND PRODUCTS THEREFROM - A feed/food process and product that provides a stabilized feed/food supplement that enhances the conversion efficiency and levels of omega 3 essential fatty acids including docasahexaenoic acid (DHA), Docosapentanenoic acid (DPA) and eicosapentenoic acid (EPA) in livestock/human products therefrom e.g. poultry. Specifically, Chickens (var. Ross) are fed a stabilized form of non-marine, non algal source omega 3 fatty acids including DHA, EPA, DPA for 5 weeks during a total 6 week production period that results in conversion efficiencies and increased levels of omega 3 fatty acids including DHA, EPA, DPA in various cuts and parts of poultry meat (legs, breasts etc. with or without skin) that also results in improved production benefits in terms of weight gains, improved flavour, taste, tenderness and less stress in poultry during production/transporting and the production of feeds/food and or ingredients with reduced levels of contaminants e.g. heavy metals. | 2009-02-19 |
20090047379 | Benzamide Compounds Useful as High Potency Sweet Taste Enhancers - The present invention relates to novel benzamide compounds may be used to provide desirable property of sweetness and to a foodstuff, chewing gum, medicinal product, toothpaste, alcoholic beverage, aqueous beverage, snack, sauce, confection, baked good, dairy product or cereal. | 2009-02-19 |
20090047380 | Catalase gene and use thereof - The present invention relates to a gene encoding a catalase and use thereof, in particular, a brewery yeast having high sulfite-producing capability, alcoholic beverages produced with said yeast, and a method for producing said beverages. More particularly, the present invention relates to a yeast, whose capability of producing sulfite, that contribute to stability of flavor in products, is enhanced by amplifying expression level of CTA1 gene encoding a catalase Cta1p, especially non-ScCTA1 gene or ScCTA1 gene specific to a lager brewing yeast, and to a method for producing alcoholic beverages with said yeast. | 2009-02-19 |
20090047381 | AMMONIA TRANSPORTER GENE AND USE THEREOF - The present invention relates to ammonia transporter genes and use thereof. The invention relates in particular to a brewer's yeast which shows enhanced ammonia assimilation, alcoholic beverages produced using such yeast, and a method of producing such alcoholic beverages. More specifically, the invention relates to the MEP1 gene which codes for the ammonia transporter Mep1 in brewer's yeast, particularly to a yeast which can control the ammonia assimilation ability by controlling the level of expression of the nonScMEP1 gene or ScMEP1 gene characteristic to beer yeast and to a method of producing alcoholic beverages using such yeast. | 2009-02-19 |
20090047382 | PROCESS FOR STARCH LIQUEFACTION AND FERMENTATION - The presently disclosed subject matter provides improved processes for processing starch from plant sources, including processes for starch liquefaction, for simultaneous liquefaction and saccharification, and for the preparation of ethanol. These processes can be performed without a pH adjustment and at relatively low temperatures. The processes can involve the use of starch-containing plant material derived from plants that express starch-digesting enzymes. The presently disclosed subject matter further relates to improved processes for the preparation of other starch-derived products, including dried distiller grain (dried distiller grain) and dried distiller grain and solubles (dried distiller grain and solubles), and to the starch-derived products, themselves. | 2009-02-19 |
20090047383 | Manufacturing Method of Black Vinegar and Black Vinegar Manufactured by the Method - An object of the present invention is to provide a manufacturing method of black vinegar which contains sugar derived from rice and barley abundantly, and is free from precipitation, and black vinegar manufactured by the method. | 2009-02-19 |
20090047384 | LIPOLYTIC ENZYME VARIANTS - The substrate specificity of a lipolytic enzyme can be modified by making alterations to the amino acid sequence in a defined region of the lipolytic enzyme, so as to increase the level of a desired activity or to decrease the level of an undesired activity. Thus, the inventors have developed lipolytic enzyme variants with a modified amino acid sequence with a substrate specificity which can be tailored for specific uses. | 2009-02-19 |
20090047385 | NATURAL OAT-DERIVED SWEETENER - An oat-derived sweetener and methods related thereto are provided. The use of an oat-derived sweetening ingredient allows for the masking of off flavors and sweetening without the use of sugar, sucralose and acesulfame potassium or other sweetening agents that are perceived as being unhealthy. The oat-derived sweetener can be utilized in a number of food products and beverages, including oatmeal. | 2009-02-19 |
20090047386 | Cultured Dairy Products and Methods of Manufacture - The present invention is directed to cultured dairy products and more particularly to cultured cream cheese compositions which are prepared without a whey-separation step and which have reduced levels of cultured dairy materials. The present invention also relates to methods of making such cultured dairy or cream cheese products. The cultured dairy or cream cheese products contain a considerable quantity of non-cultured dairy material (generally greater than about 60 percent, and preferably about 70 to about 80 percent, of the total dairy protein). | 2009-02-19 |
20090047387 | Protease variants - The invention relates to a novel 3D structure encoding a | 2009-02-19 |
20090047388 | CALCIUM FORTIFIED CREAMED HONEY - A calcium fortified creamed honey product. An effective amount of calcium mineral having a mean particle size of about 30 nanometers to about 10 microns is added to the honey to provide not only calcium fortification but also to provide creamed honey with a smooth texture for enhanced spreadability. | 2009-02-19 |
20090047389 | BEVERAGE-INGREDIENT CAPSULE AND CAPSULE-BASED BEVERAGE PRODUCTION METHOD - A sealed capsule for containing an ingredient is provided with at least one essentially rigid inner jet direction-diverting member being arranged close to the inner side of a face of the capsule. The inner jet direction-diverting member is designed to divert the direction of at least a portion of a water jet injected through an opening produced in the face. The invention further proposes the dynamical profiling of inner channels in at least one face of the capsule by pressing the face of the capsule against a profiling member of the beverage production device. | 2009-02-19 |
20090047390 | CHICKEN NOODLE BITES - A snack food incorporating various ingredients of chicken noodle soup is described. The processing of a chicken noodle soup mixture begins with three separate batch operations (e.g., pasta, chicken/vegetable filling, and broth) that are completed before moving to a continuous forming process, such as a triple cold forming extrusion operation. Extrusion typically begins with a machine kneading and then forming a pasta shell under high pressure through a custom die. Concurrently, the chicken/vegetable filling and broth move through the extruder in separate streams allowing for two distinct fillings one inside the other (e.g., broth inside chicken), filling approximately 75% of the pasta shell's volume allowing room for closing. The product is simultaneously cut and sealed at a suitable length. | 2009-02-19 |
20090047391 | Method Of Preparing Dough Products - The present relates to a method of preparing a dough product comprising: mixing flour, water and optionally other bakery ingredients to form a dough; and applying a coating composition directly to the outside surface of the dough at a stage of the dough manufacture when the dough is no longer subjected to kneading or lamination, said coating composition containing, calculated on dry matter, emulsifier in an amount of 10-100% and polysaccharide in an amount of 0-20%. The dough products obtained by the present method offer the advantage that they can be baked or fried to yield a product that will retain a crispy crust for a considerable period of time and even after reheating of the baked or fried product. Other aspects of the invention relate to dough products that can be obtained by the aforementioned method as well as to baked and fried products obtained by baking or flying such a dough product. | 2009-02-19 |
20090047392 | Methods for Producing Sterol-Containing Compositions - The invention relates to a method for producing coated sterol powder, wherein a) a carbohydrate and/or a protein and/or a protein-containing auxiliary agent is dissolved or dispersed in water or in an aqueous suspension medium, b) said sterol and/or stanol particles are added to the solution/dispersion, c) the thus obtained solution is homogenised in a homogeniser or a colloid mill in the circuit, d) one part of the homogenate is extracted in a continuous manner from the circuit and directly e) introduced into a dry-spraying system by pulverisation and spraying. The coated sterol-containing particles produced according to said method are incorporated into food based due to their good wettability and without using complex equipment, and display, in particular, good organoleptic and sensory properties in drinks. | 2009-02-19 |
20090047393 | System for combining ice cream and coatings - A system and mechanism for forming discrete units of ice cream is disclosed utilizing cryogenically cooled equipment during the manufacturing process. The discrete units are formed and then coated with one or more various confectionary substances, also using cryogenically cooled equipment, so as to result in a substantially uniformly-coated ice cream product. | 2009-02-19 |
20090047394 | VACUUM PACKED PET FOOD - A pet food packages of pet food package is chosen for visual appeal. The package includes a tray and a film that retains loose components of the pet food in a specified and consistent arrangement by vacuum conditions. | 2009-02-19 |
20090047395 | Multi-Compartment Package - A method for making a multi-compartment microwavable package having one or more open or closed compartments within the package, and method and apparatus for manufacturing the same, constructed by modification to existing vertical form, fill and seal packaging machines. The invention involves producing a multi-compartment bag having an internal permeable wall between compartments from a single sheet of flexible packaging film. A food product can be placed into the first compartment and steam pack can be placed into the second compartment. | 2009-02-19 |
20090047396 | SALTY- TASTE ENHANCER - A salty taste enhancer containing sodium lactate and/or potassium lactate as active ingredient(s). When the salty taste enhancer is used, a salty taste of a food or beverage can be enhanced without change in the taste quality by addition at an extremely small quantity. The salt composition using the salt taste enhancer has taste quality equal to that of sodium chloride and an enhanced salty taste. | 2009-02-19 |
20090047397 | Composition and Method of Preparing Ready-to-Eat Cereal with Konjac Flour as a Main Ingredient - The present invention discloses a method and composition of preparing ready-to-eat (R-T-E) cereal with konjac flour as a main ingredient. Based on the conventional method, innovations are made in mixing konjac flour with other ingredients in the composition as well as in drying the interim product. The appearance and physical property of the finale product are similar to that of the conventional R-T-E cereal, whereas konjac-associated health benefits are retained. | 2009-02-19 |
20090047398 | Meat product and method for making same - The present application is directed to a meat product, including a cut cut of meat and a seasoning and cure solution. The cut of meat having muscle fibers oriented in a substantially uniform direction. The cut of meat being sliced across the grain of the muscle fibers and the seasoning and cure solution being applied to the cut of meat. | 2009-02-19 |
20090047399 | Method of producing mixed greens - A method is provided for preparing mixed greens. Greens are immersed in an aqueous solution containing phosphoric acid, calcium chloride and a natural antibiotic, dewatered from their surfaces, cooked and mixed in predetermined amounts. Following the application of a seasoning solution containing an organic acid and a natural antibiotic thereto, the mixed greens are vacuum packed and thermally sterilized. The mixed greens prepared according to the method can preserve their fresh texture senses for a long period of time. | 2009-02-19 |
20090047400 | APPARATUS AND METHOD FOR HYBRID INFUSION OF FOOD PIECES - The present invention provides a method and an apparatus for the hybrid infusion of solutes, which comprises atmospheric infusion followed by vacuum infusion, into food pieces within a single apparatus. The apparatus comprises an internal conveyor for holding a bed of product to be infused, two retaining walls extending the length of the internal conveyor to contain the bed of product, a mixing mechanism that moves upward and downward at a predetermined velocity and periodicity to immerse floating product and gently mix, and a vacuum port for depressurizing the apparatus for predetermined periods of time during infusion and draining of the infusion solution. | 2009-02-19 |
20090047401 | Method and apparatus for making an air-containing mixture - There is disclosed a system comprising a method and an apparatus for making an air-containing mixture | 2009-02-19 |
20090047402 | Device For Frothing And Steaming Milk - A device for frothing and steaming milk comprises a steamer ( | 2009-02-19 |
20090047403 | Pomegranate processing machine - The machine removes skins from a pomegranate or other fruit or vegetable. A pair of belts are spaced apart by a gap. The belts travel in a common direction adjacent the gap and are closer together on at least portions thereof than a width of the pomegranate. Pomegranates passed through the gap are thus compressed between the two belts. One of the belts travels faster than the other belt so that both compression and a shearing force act upon the skin of the pomegranate. The skin is torn and opened to expose arils within a core of the pomegranate. An under belt preferably carries pomegranates through the gap with slots in the under belt to allow arils and juice to fall down through an opening in a deck upon which the compression belts are mounted. A tray collects the arils and juice falling through the deck below the gap. | 2009-02-19 |
20090047404 | CROSS-FLOW SPIRAL HEAT TRANSFER SYSTEM - A heat transfer system for refrigeration and/or heating of products includes a housing having an internal chamber, a baffle, a spiral pathway around the baffle, a gas flow pathway and a blower to circulate gas along the gas flow pathway. The baffle separates the chamber into upper and lower portions. The spiral pathway includes an upper spiral pathway within the upper portion, and a lower spiral pathway within the lower portion. The gas flow pathway includes an upper gas flow pathway across the upper spiral pathway and a lower gas flow pathway across the lower spiral pathway in which gas flow in the upper and lower gas flow pathways defines a circulation loop. The width of the upper gas flow pathway and upper spiral pathway are similar, and the width of the lower gas flow pathway and lower spiral pathway are similar. | 2009-02-19 |
20090047405 | FOOD COMPOSITION WITH THERAPEUTIC AGENTS - Food compositions with therapeutic agents are described. The food compositions comprise oligosaccharides and/or polysaccharides that are fractions recovered from North American Ginseng. The food compositions can be tea beverages that have improved taste characteristics and that can provide enhanced immunity when consumed. | 2009-02-19 |
20090047406 | Packaged Oxidation-Stable Oil-In-Water Emulsion - One aspect of the invention relates to a packaged, oxidation-stable oil-in-water emulsion comprising:
| 2009-02-19 |
20090047407 | METHOD AND INGREDIENT FOR INCREASING SOLUBLE FIBER CONTENT TO ENHANCE BILE ACID BINDING, INCREASE VISCOSITY, AND INCREASE HYPOCHOLESTEROLEMIC PROPERTIES - The present invention relates to a method for modifying materials that have low soluble fiber content and high insoluble fiber content so as to enhance bile acid binding capacity by increasing the level of available soluble fiber that can be obtained from such starting materials in order to create ingredients that are useable in food intermediates that are suitable for lowering unhealthy cholesterol levels. More particularly, the present invention relates to controlling the moisture content, mechanical pretreatment and alkali treatment of such starting materials as wheat bran or shorts. | 2009-02-19 |
20090047408 | Method for Improving Absorbability of Epigallocatechin Gallate, Foods, Drinks and Food/Drink Materials Using the Same and Method for Producing the Same - Provided are a food, a drink and a food/drink material having improved EGCg absorbability, and a method of producing the same, by improving the absorbability of EGCg to be taken in. The contents of caffeine and/or epigallocatechin gallate are regulated so that the ratio by mass of caffeine to epigallocatechin gallate contained in a food, drink, food/drink material or oral ingesta comes close to 0.4. | 2009-02-19 |